학술논문

Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study
Document Type
Article
Source
In: Annals of Hematology. (Annals of Hematology, August 2023, 102(8):2127-2136)
Subject
Language
English
ISSN
14320584
09395555